GJA4 gene inhibition may represent a potential target for novel antithrombotic therapies

2 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Biomarkers to assess cardiovascular risk Cardiovascular Risk Assessment ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by